Subtype
Testicular Neoplasm
CI-CAN-00004087Explore in graph →
Non-malignant50 active trials3 approved drugs
Loading cancer entity…
Subtype
CI-CAN-00004087Explore in graph →
Clinical trials
286 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04150848 | A Biobehavioral Intervention for Young Men With Testicular Cancer | unknown | Phase 2 | 100 | University of California, IrvineOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT01172912 | High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy | unknown | Phase 2 | 47 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 12, 2013 |
| clinicaltrials |
| NCT00551122 | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors(GemTIP) | unknown | Phase 1 / Phase 2 | 23 | University of SouthamptonOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00772694 | Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy(GCT) | unknown | Phase 2 | 20 | Fondation Wygrajmy ZdrowieOTHER | 1 | Oct 24, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Dec 19, 2020source: clinicaltrials